Clasp Therapeutics是一家总部位于美国马萨诸塞州的生物技术公司，致力于开发针对每位患者免疫系统的模块化T细胞诱导体（TCE），这些TCE针对常见的 ...

Clasp’s platform identifies mutation-associated neoantigens and develops TCEs that can selectively bind HLA (human leukocyte antigen)-presented peptides derived from these oncogenic drivers.

CLASP II D Trial: A Randomized Comparison of Transcatheter Edge-to-Edge Repair Devices for Degenerative Mitral Regurgitation – Clinical Outcomes and Echo Findings ... 03:31 C. Michael Gibson, Scott ...